Church & Dwight (CHD) Q4 2025 Earnings Transcript

Core Insights - The company reported total sales of $6.2 billion, with a 3.9% growth in Q4 and a full-year growth of 1.6%, despite portfolio changes [3][5] - Organic sales growth was 0.7% for the full year, but adjusted for exited VMS business, organic growth was 2% [3][5] - Gross margin increased by 90 basis points year-over-year in Q4 and is projected to improve by 100 basis points in 2026 [3][5] - The company achieved an EPS of $0.86 in Q4, which is 12% higher than the previous year, with a 2026 outlook targeting 5%-8% growth [3][5] - Free cash flow for 2025 was $1.2 billion, with a conversion rate of 127%, and guidance for 2026 is $1.15 billion [3][5] - A 4.2% increase in dividends was announced for 2026, marking the 125th consecutive year of dividend payments [3][5] Portfolio Reshaping - The company divested low-margin and private-label-heavy businesses, reducing private label exposure from 12% to 5% [5][16] - The acquisition of Touchland contributed positively to sales and is being expanded internationally through premium partnerships [5][8] Brand Performance - Four of the eight core power brands grew market share, with Hero and TheraBreath achieving double-digit growth [7][11] - ARM & HAMMER attained a record 14.5% wash-load share in laundry, while TheraBreath reached nearly 22% market share in mouthwash [8][56] - The skincare brand Hero grew at three times the category rate, achieving a 19% share [8][64] Growth Outlook - The company projects 2026 organic growth of 3%-4%, with U.S. growth at 3% and international growth at 8% [7][38] - Marketing investment is planned at 11% of sales for 2026, consistent with the company's growth framework [7][38] - E-commerce penetration increased from 2% to 24% of total sales, driving above 14% growth for key brands [7][8] Innovation and Expansion - More than half of organic growth is expected to come from new product development, with a 2026 innovation pipeline including launches in oral care and premium laundry products [5][8] - The international business registered 5.5% organic growth in 2025, supported by brand localization and regional innovation initiatives [8][28] - The company aims to grow ARM & HAMMER from $2 billion to $3 billion and TheraBreath from $1 billion to $1.5 billion over time [21][22]